Form 4 for CYTK CYTOKINETICS INC
Accepted 2025-12-29 00:00:00 ET · period of report 2025-12-22 · accession 0001061983-25-000055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-29 | 2025-12-22 | CYTK | Malik Fady Ibraham | EVP Research, Development | F - Tax | $62.72 | -1,016 | 141.5K | -0.7% | -$63.7K | |
| M | 2025-12-29 | 2025-12-22 | CYTK | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +4,000 | 142.6K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-22 | F | D | 1,016 | $62.72 | 141,536 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-22 | A | A | 2,000 | $0.00 | 140,552 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-22 | A | A | 2,000 | $0.00 | 142,552 | D | — | — |